News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|August 7, 2015

Blood Tests, Biopsies, and Symptoms

Episodes in this series

EP. 1 What Pancreatic Cancer Is and The Risk Factors

EP. 1 What Pancreatic Cancer Is and The Risk Factors

EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis

EP. 2 A Cancer Patient's First-Hand Account of a Pancreatic Cancer Diagnosis

EP. 3 Blood Tests, Biopsies, and Symptoms

EP. 3 Blood Tests, Biopsies, and Symptoms

EP. 4 Treatment Options for Pancreatic Cancer

EP. 4 Treatment Options for Pancreatic Cancer

EP. 5 Research for Pancreatic Cancer

EP. 5 Research for Pancreatic Cancer

EP. 6 Pancreatic Cancer: Staying Positive

EP. 6 Pancreatic Cancer: Staying Positive

EP. 7 Top Tips for Pancreatic Cancer Patients

EP. 7 Top Tips for Pancreatic Cancer Patients

EP. 8 Pancreatic Cancer: A Caregiver's Perspective

EP. 8 Pancreatic Cancer: A Caregiver's Perspective

EP. 9 Pancreatic Cancer: Coping With the Disease

EP. 9 Pancreatic Cancer: Coping With the Disease

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Michelle Anderson-Benjamin

Hospice May Offer Patients With Cancer Some Peace, Comfort and Control

December 18th 2025

breast cancer

New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer

December 18th 2025

Dan, a pancreatic cancer survivor

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

BySpencer Feldman

December 18th 2025

The U.S. FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer: © stock.adobe.com.

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

December 18th 2025

Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

December 17th 2025

Trending on CURE

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer

GSK’227 Wins FDA Orphan Drug Designation in Small-Cell Lung Cancer